0001209191-22-031236.txt : 20220523 0001209191-22-031236.hdr.sgml : 20220523 20220523060942 ACCESSION NUMBER: 0001209191-22-031236 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220519 FILED AS OF DATE: 20220523 DATE AS OF CHANGE: 20220523 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bagai Shaun CENTRAL INDEX KEY: 0001862613 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40738 FILM NUMBER: 22949512 MAIL ADDRESS: STREET 1: 4546 EL CAMINO REAL STREET 2: SUITE 223 CITY: LOS ALTOS STATE: CA ZIP: 94022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RenovoRx, Inc. CENTRAL INDEX KEY: 0001574094 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271448452 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 W. SANTA CLARA STREET, SUITE 900 CITY: SAN JOSE STATE: CA ZIP: 95110 BUSINESS PHONE: 408-800-2649 MAIL ADDRESS: STREET 1: 333 W. SANTA CLARA STREET, SUITE 900 CITY: SAN JOSE STATE: CA ZIP: 95110 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-05-19 0 0001574094 RenovoRx, Inc. RNXT 0001862613 Bagai Shaun C/O RENOVORX, INC. 4546 EL CAMINO REAL, SUITE B1 LOS ALTOS CA 94022 1 1 0 0 Chief Executive Officer Common Stock 2022-05-19 4 P 0 5500 2.05 A 251557 D Includes 246,057 shares previously reported on a Form 3 filed on August 25, 2021 as a fully vested stock option exercisable at $0.15 per share. The option was exercised in full prior to the Issuer's initial public offering. /s/ Shaun Bagai 2022-05-23